scanX
Home
Jubilant Pharmova

Jubilant Pharmova

1,138.50
+8.15
(0.72%)
Market Cap (₹ Cr.)
₹18,014
52 Week High
1,309.90
Book Value
₹341
52 Week Low
409.40
PE Ratio
62.37
PB Ratio
3.03
PE for Sector
36.27
PB for Sector
4.84
ROE
1.34 %
ROCE
4.58 %
Dividend Yield
0.44 %
EPS
₹14.96
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
7.15 %
Net Income Growth
212.02 %
Cash Flow Change
47.01 %
ROE
211.41 %
ROCE
97.57 %
EBITDA Margin (Avg.)
11.09 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
747
682
746
653
637
592
600
620
731
685
756
940
972
831
951
865
870
796
837
807
874
763
774
841
380
183
257
164
248
215
329
191
214
233
205
194
256
186
210
Expenses
898
598
622
569
555
495
499
541
638
602
623
743
800
746
804
759
809
692
673
708
698
623
642
708
311
172
154
173
220
209
216
185
198
213
186
176
194
177
172
EBITDA
-151
84
124
84
82
97
100
80
93
83
133
197
172
85
147
106
61
104
164
98
176
140
132
134
69
11
104
-9
28
6
113
6
16
20
19
18
62
10
38
Operating Profit %
-25 %
9 %
11 %
10 %
11 %
14 %
12 %
9 %
10 %
9 %
14 %
19 %
16 %
8 %
8 %
11 %
5 %
11 %
10 %
10 %
10 %
16 %
15 %
14 %
15 %
1 %
-7 %
-16 %
6 %
-4 %
-0 %
-9 %
-4 %
-5 %
-3 %
-3 %
4 %
-9 %
-6 %
Depreciation
23
21
22
22
22
20
20
21
20
20
21
21
21
21
22
22
22
24
25
28
30
30
30
30
11
9
9
9
9
9
11
12
11
11
12
12
13
13
13
Interest
47
57
53
45
46
44
45
42
43
35
33
34
33
31
34
32
32
33
32
35
36
40
27
23
12
3
3
3
3
3
4
6
6
6
7
8
8
8
8
Profit Before Tax
-221
6
49
17
14
32
35
17
30
27
78
143
119
33
91
52
6
47
106
35
110
71
75
81
46
-1
92
-21
15
-7
98
-11
-1
2
0
-2
42
-11
17
Tax
-14
3
-2
-12
18
11
11
9
-8
5
21
45
32
10
12
16
-1
15
-37
0
-1
19
13
16
11
0
16
-2
-0
0
14
-0
-1
0
0
-0
7
0
5
Net Profit
-207
3
52
29
-10
21
24
8
26
22
57
98
86
24
80
37
7
32
143
35
111
52
63
65
35
-1
86
-16
10
-5
92
-6
-31
2
-0
-2
33
-10
11
EPS in ₹
-12.99
0.18
3.24
1.82
-0.65
1.32
1.51
0.52
1.62
1.40
3.57
6.15
5.42
1.50
5.00
2.30
0.47
2.03
8.98
2.17
6.98
3.27
3.93
4.06
2.21
-0.05
5.42
-0.98
0.66
-0.33
5.77
-0.37
-1.94
0.12
-0.03
-0.15
2.05
-0.64
0.66
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
5,188
4,329
4,391
4,625
4,864
5,433
1,845
1,829
3,008
2,992
Fixed Assets
1,446
1,415
1,421
1,438
1,491
1,865
127
124
687
711
Current Assets
1,654
1,068
1,144
1,326
1,281
1,722
66
48
579
541
Capital Work in Progress
20
36
65
115
284
59
0
0
47
37
Investments
0
1,709
1,710
1,706
1,764
1,764
1,646
1,646
1,657
1,657
Other Assets
3,722
1,169
1,195
1,365
1,325
1,746
71
60
617
587
Total Liabilities
3,243
2,316
2,348
2,375
2,523
2,826
562
548
594
617
Current Liabilities
1,308
1,155
911
1,238
1,298
1,375
120
38
361
315
Non Current Liabilities
1,935
1,160
1,438
1,137
1,226
1,451
442
510
233
302
Total Equity
1,945
2,014
2,043
2,249
2,340
2,607
1,282
1,282
2,415
2,375
Reserve & Surplus
1,929
1,998
2,027
2,233
2,324
2,591
1,267
1,266
2,399
2,359
Share Capital
16
16
16
16
16
16
16
16
16
16
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-42
-98
38
-40
-18
78
5
-18
-12
25
Investing Activities
1,319
522
-43
-127
-285
-198
178
93
31
-40
Operating Activities
286
164
419
558
182
317
608
-4
-65
143
Financing Activities
-1,647
-784
-338
-470
85
-41
-782
-107
22
-78
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
FIIs
25.69 %
24.82 %
23.14 %
23.18 %
23.45 %
23.47 %
23.06 %
23.38 %
0.00 %
23.20 %
23.21 %
20.29 %
19.06 %
19.49 %
17.94 %
DIIs
1.28 %
1.76 %
1.03 %
1.06 %
0.63 %
0.62 %
1.61 %
1.62 %
24.85 %
1.63 %
1.65 %
2.89 %
3.78 %
4.07 %
5.66 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.24 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
22.29 %
22.68 %
25.09 %
25.01 %
25.18 %
25.17 %
24.59 %
24.19 %
23.10 %
23.90 %
23.88 %
25.56 %
25.90 %
25.18 %
25.17 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,795.30 4,26,517.78 38.05 49,887.17 12.06 9,648 27.35 44.59
Divis Laboratories
5,998.35 1,58,636.06 86.40 8,184.00 0.89 1,600 46.55 61.47
Cipla
1,486.50 1,18,365.23 25.64 26,520.66 14.17 4,155 12.95 41.66
Mankind Pharma
2,551.60 1,02,273.02 48.35 10,615.63 19.57 1,942 28.89 44.48
Dr Reddys Laboratories
1,214.45 99,671.43 18.67 28,905.40 12.36 5,578 -9.47 36.74
Zydus Life Science
949.05 95,013.64 22.21 19,831.50 13.82 3,831 14.57 33.61
Lupin
2,071.35 93,214.31 35.49 20,141.50 19.94 1,936 73.52 42.68
Aurobindo Pharma
1,223.70 71,496.23 19.60 29,559.25 17.55 3,169 8.65 19.57
Alkem Laboratories
5,583.35 66,992.27 30.81 12,978.42 9.84 1,811 14.16 39.72
Glenmark Pharmaceuticals
1,478.20 41,349.03 - 12,653.09 6.58 -1,831 675.84 30.06

Corporate Action

Technical Indicators

RSI(14)
Neutral
45.49
ATR(14)
Less Volatile
60.21
STOCH(9,6)
Neutral
26.78
STOCH RSI(14)
Oversold
2.34
MACD(12,26)
Bearish
-12.58
ADX(14)
Weak Trend
19.65
UO(9)
Bearish
46.00
ROC(12)
Downtrend But Slowing Down
-9.10
WillR(14)
Neutral
-76.48
Bearish
5
Neutral
3
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.